Literature DB >> 2684973

Biosynthesis of N-glycolyneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool.

E A Muchmore1, M Milewski, A Varki, S Diaz.   

Abstract

N-Glycolylneuraminic acid (Neu5Gc) is an oncofetal antigen in humans and is developmentally regulated in rodents. We have explored the biology of N-acetylneuraminic acid hydroxylase, the enzyme responsible for conversion of the parent sialic acid, N-acetylneuraminic acid (Neu5Ac) to Neu5Gc. We show that the major sialic acid in all compartments of murine myeloma cell lines is Neu5Gc. Pulse-chase analysis in these cells with the sialic acid precursor [6-3H]N-acetylmannosamine demonstrates that most of the newly synthesized Neu5Gc appears initially in the cytosolic low-molecular weight pool bound to CMP. The percentage of Neu5Gc on membrane-bound sialic acids closely parallels that in the CMP-bound pool at various times of chase, whereas that in the free sialic acid pool is very low initially, and rises only later during the chase. This implies that conversion from Neu5Ac to Neu5Gc occurs primarily while Neu5Ac is in its sugar nucleotide form. In support of this, the hydroxylase enzyme from a variety of tissues and cells converted CMP-Neu5Ac to CMP-Neu5Gc, but showed no activity towards free or alpha-glycosidically bound Neu5Ac. Furthermore, the majority of the enzyme activity is found in the cytosol. Studies with isolated intact Golgi vesicles indicate that CMP-Neu5Gc can be transported and utilized for transfer of Neu5Gc to glycoconjugates. The general properties of the enzyme have also been investigated. The Km for CMP-Neu5Ac is in the range of 0.6-2.5 microM. No activity can be detected against the beta-methylglycoside of Neu5Ac. On the other hand, inhibition studies suggest that the enzyme recognizes both the 5'-phosphate group and the pyrimidine base of the substrate. Taken together, the data allow us to propose pathways for the biosynthesis and reutilization of Neu5Gc, with initial conversion from Neu5Ac occurring primarily at the level of the sugar nucleotide. Subsequent release and reutilization of Neu5Gc could then account for the higher steady-state level of Neu5Gc found in all of the sialic acid pools of the cell.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684973

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Metabolic radiolabeling of animal cell glycoconjugates.

Authors:  S Diaz; A Varki
Journal:  Curr Protoc Mol Biol       Date:  2001-05

2.  Housekeeping promoter 5'pcmah-2 of pig CMP-N-acetylneuraminic acid hydroxylase gene for NeuGc expression.

Authors:  Kwon-Ho Song; Choong-Hwan Kwak; Un-Ho Jin; Sun-Hyung Ha; Jun-Young Park; Fukushi Abekura; Young-Chae Chang; Seung-Hak Cho; Kichoon Lee; Tae-Wook Chung; Ki-Tae Ha; Young-Choon Lee; Cheorl-Ho Kim
Journal:  Glycoconj J       Date:  2016-05-17       Impact factor: 2.916

3.  Purification, characterization and reconstitution of CMP-N-acetylneuraminate hydroxylase from mouse liver.

Authors:  P Schneckenburger; L Shaw; R Schauer
Journal:  Glycoconj J       Date:  1994-06       Impact factor: 2.916

4.  The role of CMP-N-acetylneuraminic acid hydroxylase in determining the level of N-glycolylneuraminic acid in porcine tissues.

Authors:  Y N Malykh; L Shaw; R Schauer
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

5.  Glycoengineering of Mammalian Expression Systems on a Cellular Level.

Authors:  Kelley M Heffner; Qiong Wang; Deniz Baycin Hizal; Özge Can; Michael J Betenbaugh
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 6.  Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.

Authors:  Kayluz Frias Boligan; Circe Mesa; Luis Enrique Fernandez; Stephan von Gunten
Journal:  Cell Mol Life Sci       Date:  2014-12-07       Impact factor: 9.261

7.  CMP-N-acetylneuraminic acid hydroxylase activity determines the wheat germ agglutinin-binding phenotype in two mutants of the lymphoma cell line MDAY-D2.

Authors:  L Shaw; S Yousefi; J W Dennis; R Schauer
Journal:  Glycoconj J       Date:  1991-10       Impact factor: 2.916

8.  Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer.

Authors:  Thomas N Seyfried; Purna Mukherjee
Journal:  J Oncol       Date:  2010-06-20       Impact factor: 4.375

9.  Defective glucuronic acid transport from lysosomes of infantile free sialic acid storage disease fibroblasts.

Authors:  H J Blom; H C Andersson; R Seppala; F Tietze; W A Gahl
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

Review 10.  Why Is N-Glycolylneuraminic Acid Rare in the Vertebrate Brain?

Authors:  Leela R L Davies; Ajit Varki
Journal:  Top Curr Chem       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.